Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.61
+0.15 (2.01%)
At close: Jul 2, 2026, 4:00 PM EDT
7.60
-0.01 (-0.13%)
After-hours: Jul 2, 2026, 5:56 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $469.93 million as of July 2, 2026. Its market cap has increased by 112.15% in one year.
Market Cap
469.93M
Enterprise Value
365.43M
1-Year Change
112.15%
Ranking
Category
Stock Price
$7.61
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $469.93M, an increase of 32.45%. That is a compound annual growth rate of 9.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 469.93M | 144.08% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 502.06M |
| Zura Bio | 491.14M |
| Silence Therapeutics | 490.76M |
| Prelude Therapeutics | 486.96M |
| C4 Therapeutics | 475.44M |
| Artiva Biotherapeutics | 466.93M |
| Evommune | 466.80M |
| Benitec Biopharma | 454.16M |